Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need ...

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

As the deadly grip of malaria continues to claim thousands of lives each year, a powerful shift is underway in Uganda—one ...

Bharat Biotech & GSK to slash malaria vaccine price by over 50% by 2028, aiming for increased access in Africa. A major step ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

Bharat Biotech and GSK have announced plans to reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028.

Bharat Biotech and GSK announce price reduction for the world’s first malaria vaccine to under $5. This move aims to improve ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...